| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net loss for the period | ||||||||
-61,866 | -61,469 | -60,211 | -56,101 | -46,657 | -39,027 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash (used in) from operating activities: | ||||||||
Depreciation | ||||||||
2,900 | 2,800 | 2,658 | 2,476 | 2,259 | 2,000 | 0 | 0 | 0 |
Amortization of intangible assets | ||||||||
5,300 | 5,300 | 5,000 | 4,171 | 3,271 | 2,500 | 0 | 0 | 0 |
Amortization of debt discount and issuance costs | ||||||||
0 | - | - | - | - | - | - | - | - |
Amortization of contract acquisition costs | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Non-cash operating lease cost | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Unrealized (gain) loss foreign exchange | ||||||||
360 | -617 | -8 | -18 | -386 | -134 | 0 | 0 | 0 |
Accrued interest on convertible debt | ||||||||
0 | - | - | - | - | - | - | - | - |
Share-based compensation | ||||||||
37,431 | 33,792 | 32,901 | 29,367 | 23,506 | 20,837 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | ||||||||
5,465 | 13,623 | 6,571 | 5,768 | 10,707 | 12,387 | 0 | 0 | 0 |
Contract acquisition costs | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Other assets | ||||||||
6,933 | 8,513 | 9,602 | 6,584 | 7,064 | 6,435 | 0 | 0 | 0 |
Accounts payable | ||||||||
-763 | -1,286 | 4,436 | 2,875 | -570 | 1,643 | 0 | 0 | 0 |
Accrued expenses and other current liabilities | ||||||||
4,529 | 5,758 | 4,623 | 6,890 | 5,377 | 9,987 | 0 | 0 | 0 |
Contract liabilities - deferred revenue | ||||||||
16,601 | 19,729 | 14,303 | 16,664 | 20,640 | 24,778 | 0 | 0 | 0 |
Operating lease liabilities | ||||||||
-216 | -85 | 0 | 0 | 0 | - | - | - | - |
Net cash from (used in) operating activities | ||||||||
-3,883 | -14,517 | -12,375 | -6,678 | -10,036 | 3,435 | 0 | 0 | 0 |
Cash flows from investing activities: | ||||||||
Acquisition of property and equipment | ||||||||
4,053 | 2,191 | 4,164 | 5,202 | 5,033 | 5,006 | 0 | 0 | 0 |
Net cash used in investing activities | ||||||||
-4,053 | -2,191 | -63,657 | -64,695 | -64,526 | -64,499 | 0 | 0 | 0 |
Proceeds from issuance of ordinary shares related to exercise of stock awards | ||||||||
5,780 | 5,805 | 4,977 | 5,294 | 6,113 | 7,053 | 0 | 0 | 0 |
Proceeds from issuance of ordinary shares related to employee stock purchase plan | ||||||||
4,752 | 4,738 | 0 | 0 | 0 | - | - | - | - |
Repayment of borrowings | ||||||||
201 | 203 | 170 | 124 | 215 | 242 | 0 | 0 | 0 |
Net cash from financing activities | ||||||||
157,829 | 157,838 | 158,694 | 9,248 | 9,976 | 8,616 | 0 | 0 | 0 |
Net increase (decrease) in cash and cash equivalents | ||||||||
149,893 | 141,130 | 82,662 | -62,125 | -64,586 | -52,448 | 0 | 0 | 0 |
Effect of exchange rate changes on cash and cash equivalents | ||||||||
-1,515 | 1,841 | -798 | 847 | -1,739 | -836 | 0 | 0 | 0 |